Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: BJU Int. 2014 Aug 13;115(2):308–318. doi: 10.1111/bju.12802

Table 2. Bivariate analysis: Baseline characteristics and their correlation with risk of BPH progression.

Characteristics identified within our literature search as well as a number of other factors collected within MTOPS data were analyzed. Variables are plotted with their model coefficients and hazard ratios. Standard errors are noted for each estimate.

Variable Estimate SE p-value HR
Age, year 0.0373 0.0072 <.0001 1.038
AUA Symptom Score −0.0240 0.0093 0.0098 0.976
Prostate volume, ml 0.0096 0.0021 <.0001 1.010
Maximal urinary flow rate, ml/sec −0.0587 0.0204 0.004 0.943
Post-voiding residual volume, ml 0.0018 0.0005 0.001 1.002
Serum PSA, ng/ml 0.1096 0.0223 <.0001 1.116
BPH Impact Index 0.0452 0.0192 0.0184 1.046
Serum glucose, ng/dl −0.0005 0.0013 0.7126 1.000
BMI, kg/m2 −0.0018 0.0130 0.8930 0.998
Primary school education only, yes vs. no 0.3511 0.2420 0.1469 1.421
Family history of prostate cancer
   Yes −0.0757 0.1597 0.6357 0.927
   No 1.00 (reference)
   Unknown 0.2040 0.1480 0.1682 1.226
Impotence, n (%)
   Yes 0.2117 0.1194 0.0762 1.236
   No 1.00 (reference)
   Intermittent 0.0072 0.1374 0.9583 1.007
History of diabetes, yes vs. no 0.0826 0.1854 0.6561 1.086
History of hypertension, yes vs. no 0.0173 0.1186 0.8843 1.017

SE = standard error; HR = hazard ratio; CL = confidence limit; PSA = prostate-specific antigen; AUA = American Urological Association